NEW YORK, NY / ACCESS Newswire / January 16, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Bath & Body Works, Inc. ("Bath & Body Works" or the "Company") (NYSE:BBWI).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
The class action concerns whether Bath & Body Works and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
You have until March 16, 2026, to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired Bath & Body Works securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.�����
[Click here for information about joining the class action]
On August 28, 2025, Bath & Body Works reported its second quarter 2025 financial results. Among other items, the Company reported earnings per diluted share of $0.30, representing a decline of 55.8% year over year and missing the Company’s prior guidance on the low end by $0.03. Bath & Body Works also reported net income of $64 million, a decline of 57.9% year over year. The Company also announced that it was cutting its full year guidance for earnings per diluted share by $0.03 at the midpoint, to a range of $3.28 to $3.53.
On this news, Bath & Body Works’ stock price fell $2.18 per share, or 6.9%, to close at $29.36 per share on August 28, 2025.
Then, on November 20, 2025, Bath & Body Works reported third quarter 2025 financial results. The Company reported a 1% year over year decline in revenue, missing its guidance of 1-3% growth for the quarter. Bath & Body Work’s net income also declined, falling 26% to $77 million. Finally, the Company announced that it was slashing full year guidance for net sales from a previously positive 1.5%-2.7% to negative "high single digits." Bath & Body Works also cut expected earnings per diluted share from a range of $3.28 to $3.53 to "at least $2.83." In an investor presentation published the same day, the Company announced a new business strategy and admitted that its strategy of "adjacencies, collaborations and promotions" had "not grown our total customer base."
On this news, Bath & Body Works’ stock price fell $5.22 per share, or 24.8%, to close at $15.82 per share on November 20, 2025.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. â?¯Prior results do not guarantee similar outcomes.
SOURCE: Pomerantz LLP
View the original press release on ACCESS Newswire
COMTEX_472063771/2457/2026-01-16T18:55:10